publication date: Nov. 16, 2010

In this issue:


Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study Lasofoxifene Reduced Breast Cancer Risk 

In Postmenopausal Osteoporotic Women

Patient Satisfaction 



Higher With Silicone Implants

More Breast Cancer Patients Opting For Double Mastectomy BRAF Inhibitor Shrank Melanoma Tumors In Phase II Trial Prostate Ca. Patients On ADT Had Higher Risk of Colon Cancer NCI-Approved Trials Listed



Download PDF

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.